Day One Biopharmaceuticals
DAWN
DAWN
180 hedge funds and large institutions have $758M invested in Day One Biopharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 73 increasing their positions, 42 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
6% more funds holding
Funds holding: 170 → 180 (+10)
4.18% less ownership
Funds ownership: 83.42% → 79.24% (-4.2%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
180
Holding in Top 10
2
Calls
$7.37M
Puts
$6.69M
Top Buyers
| 1 | +$21.1M | |
| 2 | +$9.37M | |
| 3 | +$8.76M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$6.09M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.92M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$28.6M | |
| 3 | -$23.8M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$15.6M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$15.4M |
